La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Pediatrix Medical Group Gestione
Gestione criteri di controllo 3/4
Pediatrix Medical Group's Il CEO è Jim Swift, nominato in Jan2023, e ha un mandato di 1.58 anni. la retribuzione annua totale è $ 2.24M, composta da 29% di stipendio e 71% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.21% delle azioni della società, per un valore di $ 1.89M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.6 anni e 4.1 anni.
Informazioni chiave
Jim Swift
Amministratore delegato
US$2.2m
Compenso totale
| Percentuale dello stipendio del CEO | 29.0% |
| Mandato del CEO | 1.7yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 2.7yrs |
| Durata media del Consiglio di amministrazione | 4.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)
Sep 28
Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$252m |
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
Compensazione vs Mercato: La retribuzione totale di Jim ($USD 2.24M ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 3.30M ).
Compensazione vs guadagni: La retribuzione di Jim è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Jim Swift (62 yo)
1.7yrs
Mandato
US$2,237,839
Compensazione
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | US$2.24m | 0.20% $ 1.9m | |
| Executive VP & CFO | 4yrs | US$1.78m | 0.21% $ 2.0m | |
| Executive VP | 1.9yrs | US$1.83m | 0.19% $ 1.8m | |
| Senior VP & Chief Accounting Officer | 8.3yrs | US$1.43m | Nessun dato | |
| Senior VP & Chief Information Officer | 2.7yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Administration & Managed Care | no data | Nessun dato | Nessun dato | |
| Senior VP of Finance | no data | Nessun dato | Nessun dato | |
| Senior VP | 3.1yrs | Nessun dato | Nessun dato | |
| President of Regional Operations (Central) | no data | Nessun dato | Nessun dato | |
| President of Regional Operations (South-Central) | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Operations | no data | Nessun dato | Nessun dato | |
| President of Regional Operations (West) | 2.4yrs | Nessun dato | Nessun dato |
2.7yrs
Durata media
61.5yo
Età media
Gestione esperta: Il team dirigenziale di MD è considerato esperto (durata media dell'incarico 2.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$2.24m | 0.20% $ 1.9m | |
| Chair | 4.2yrs | US$554.45k | 0.20% $ 1.9m | |
| Lead Independent Director | 4.2yrs | US$295.00k | 0.081% $ 769.2k | |
| Independent Director | 4.2yrs | US$252.50k | 0.065% $ 615.3k | |
| Independent Director | 1.3yrs | US$201.00k | 0.035% $ 328.7k | |
| Independent Director | 4.2yrs | US$230.00k | 0.065% $ 615.2k | |
| Independent Director | 4.2yrs | US$245.00k | 0.043% $ 405.7k | |
| Board Observer | 4.2yrs | Nessun dato | Nessun dato | |
| Independent Director | 5.3yrs | US$242.50k | 0.069% $ 654.8k | |
| Independent Director | 2.3yrs | US$230.00k | 0.023% $ 219.0k |
4.2yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MD sono considerati esperti (durata media dell'incarico 4.1 anni).